相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
Andrea Leonardi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
Gabor Hollo et al.
DRUGS (2018)
Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting
Christophe Baudouin et al.
ACTA OPHTHALMOLOGICA (2018)
Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
Pierre-Jean Pisella et al.
CLINICAL OPHTHALMOLOGY (2018)
One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease
Christophe Baudouin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye
Christophe Baudouin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts
Frederic Lallemand et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease
Stephen C. Pflugfelder et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
TFOS DEWS II Report Executive Summary
Jennifer P. Craig et al.
OCULAR SURFACE (2017)
Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting
Gerd Geerling et al.
OCULAR SURFACE (2017)
TFOS DEWS II Management and Therapy Report
Lyndon Jones et al.
OCULAR SURFACE (2017)
TFOS DEWS II Definition and Classification Report
Jennifer P. Craig et al.
OCULAR SURFACE (2017)
Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease
Sheridan M. Hoy
DRUGS (2017)
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
Christophe Baudouin et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Immunomodulation on the ocular surface: a review
Anna M. Ambroziak et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial
Andrea Leonardi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2016)
Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study
Pierre-Yves Robert et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2016)
Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye
Philippe Daull et al.
EXPERIMENTAL EYE RESEARCH (2016)
Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma
Anastasios G. P. Konstas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990-2010: A Meta-Analysis
Rupert R. A. Bourne et al.
PLOS ONE (2016)
Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease
Quianta L. Moore et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
Adam R. Thode et al.
DRUGS (2015)
Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
M. Saini et al.
EYE (2015)
Evaluation of dry eye after femtosecond laser-assisted cataract surgery
Yinhui Yu et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2015)
Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - A randomised comparative study
M. Amrane et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2014)
Ocular Surface Disease Exacerbated Glaucoma: Optimizing the Ocular Surface Improves Intraocular Pressure Control
Ruchika Batra et al.
JOURNAL OF GLAUCOMA (2014)
Benefits of cetalkonium chloride cationic oil- in- water nanoemulsions for topical ophthalmic drug delivery
Philippe Daull et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Treatment of Blepharitis: Recent Clinical Trials
Stephen C. Pflugfelder et al.
OCULAR SURFACE (2014)
Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits
Philippe Daull et al.
CORNEA (2013)
Preservative Exposure and Surgical Outcomes in Glaucoma Patients: The PESO Study
Corey Boimer et al.
JOURNAL OF GLAUCOMA (2013)
Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting
Christophe Baudouin et al.
OCULAR SURFACE (2013)
Ocular Surface Disease and Quality of Life in Patients With Glaucoma
Simon E. Skalicky et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction
Pinnita Prabhasawat et al.
CORNEA (2012)
The Effect of Additional Topical Cyclosporine or Vitamin A on the Ocular Surface during Antiglaucoma Medication Administration
Hyun Kyung Cho et al.
OPHTHALMIC RESEARCH (2012)
Improving Awareness, Identification, and Management of Meibomian Gland Dysfunction
Gary N. Foulks et al.
OPHTHALMOLOGY (2012)
Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb
Frederic Lallemand et al.
JOURNAL OF DRUG DELIVERY (2012)
A Practical Treatment Algorithm for Managing Ocular Surface and Tear Disorders
Scheffer C. G. Tseng
CORNEA (2011)
Medical treatment of glaucoma: present and future
Paolo Fogagnolo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Robert D. Fechtner et al.
CORNEA (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
A Large Prospective Observational Study of Novel Cyclosporine 0.1% Aqueous Ophthalmic Solution in the Treatment of Severe Allergic Conjunctivitis
Nobuyuki Ebihara et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Topical Ophthalmic Cyclosporine: Pharmacology and Clinical Uses
Eric Donnenfeld et al.
SURVEY OF OPHTHALMOLOGY (2009)
Preservatives in topical ophthalmic medications: historical and clinical perspectives
P. David Freeman et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2009)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
Changes of tear film and tear secretion after phacoemulsification in diabetic patients
Xi Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2008)
The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways
Christophe Baudouin et al.
OPHTHALMOLOGY (2008)
Ocular symptoms and signs with preserved and preservative-free glaucoma medications
N. Jaenen et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2007)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction
HD Perry et al.
CORNEA (2006)
Topical ciclosporin in the treatment of ocular surface disorders
S Tatlipinar et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years
LD Barber et al.
OPHTHALMOLOGY (2005)
Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis Sicca
B Strong et al.
CORNEA (2005)
Inhibitors of the calcineurin/NFAT pathway
S Martínez-Martínez et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients
MA Di Pascuale et al.
OPHTHALMOLOGY (2004)
The role of the lacrimal functional unit in the pathophysiology of dry eye
ME Stern et al.
EXPERIMENTAL EYE RESEARCH (2004)
A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis
EK Akpek et al.
OPHTHALMOLOGY (2004)
Antiinflammatory therapy for dry eye
SC Pflugfelder
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Survey of complications and recommendations for management in dissatisfied patients seeking a consultation after refractive surgery
NS Jabbur et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Changes in the tear film and ocular surface from dry eye syndrome
ME Johnson et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2004)
Thygeson's superficial punctate keratitis - Ten years' experience
PK Nagra et al.
OPHTHALMOLOGY (2004)
Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis
YM Li et al.
BIOCHEMICAL JOURNAL (2004)
Cyclophilin D as a drug target
PC Waldmeier et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Calcium signalling in lymphocytes
MM Winslow et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Cyclosporine A delivery to the eye: A pharmaceutical challenge
F Lallemand et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2003)
Outcomes of phacoemulsification in patients with dry eye
J Ram et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2002)
NFAT: ubiquitous regulator of cell differentiation and adaptation
V Horsley et al.
JOURNAL OF CELL BIOLOGY (2002)
Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine
L Kung et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2001)
Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion
K Turner et al.
CORNEA (2000)
Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease -: A dose-ranging, randomized trial
D Stevenson et al.
OPHTHALMOLOGY (2000)
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
K Sall et al.
OPHTHALMOLOGY (2000)
分享论文
